USA |NYSE MKT |USD
|Public Float||98.12M||P/E Ratio||-|
|% Short of Float||-||Dividend (Yield)||-|
|Held by Insiders||4.05%||Ex-Dividend Date|
|Held by Institutions||25.15%||IPO Date||Nov 12, 1992|
|Dec 20||Dec 19||Dec 18|
|Mar 21||Dec 20||Sep 20|
Asensus surgical trades on the NYSE American stock market in USA under the ticker symbol "TRXC". Asensus surgical’s stock symbol can also be displayed as "NYSEAMERICAN:TRXC".
Asensus surgical (NYSEAMERICAN:TRXC) is owned by 25.15% institutional shareholders and by 4.05% insiders. The rest is owned by the public.
Explore More Details on Asensus surgical's “Ownership” Section
Asensus surgical's key executive team includes the following managers:
Asensus surgical (NYSEAMERICAN:TRXC) is classified under the "Healthcare" sector and under the "Medical Devices" industry.
Currently the number of employees working for Asensus surgical is 160.
Asensus surgical (NYSEAMERICAN:TRXC) is headquartered in NC, United States.
Asensus surgical’s mailing address is 635 Davis Drive, Morrisville, NC, United States, 27560.
The company’s phone number is 919 765 8400.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.